Delivery Order SPE2DB24D1205-SPE2DB25FDAHF
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,630.28 for OFEV 100 mg capsules (60-count) on August 27, 2025, with completion expected by September 18, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor, leveraging the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) under a firm fixed price contract valued at $17,181.16. The order, issued on September 8, 2025, is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that reflects the company's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) under a firm fixed price contract. The award was made on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract utilizes no set-aside designation and represents a competitive award to the pharmaceutical distributor, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 18, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award to the major pharmaceutical distributor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV (pirfenidone) 100 mg capsules, 60-count packages, valued at $17,260.58 under a firm fixed-price contract type. This award, issued on July 31, 2025, represents a non-competitive delivery order for pharmaceutical supply with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of OFEV 150 mg capsules (60-count units) under a firm fixed-price arrangement. The contract, valued at $8,590.58, was competitively awarded without any set-aside designation and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV (pirfenidone) 100 mg capsules in a 60-count package, valued at $8,630.28. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply OFEV 150 MG capsules in 60-count packages. The contract has a ceiling value of $7,905.56 and a performance period through April 17, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $25,890.84 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $7,905.56. The contract has an ultimate completion date of April 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAHFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60 count) on September 10, 2025, with a ceiling value of $51,781.74 under a firm fixed-price contract type. This delivery order was awarded without set-aside provisions through open competition and is scheduled for completion by October 1, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables the company to supply an extensive range of pharmaceutical products and medical commodities to support military healthcare systems and other federal agencies globally. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a pharmaceutical distributor for defense medical procurement, with consistent awards covering specialty medications, vaccines, and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and related government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.8k | 9/10/25 |